QUADSMaster, Author at quadraScope Ventures - Page 2 of 13

Targeting chronic inflammation to treat cognitive decline – interview with ADvantage Therapeutics

QUADSMaster

June 10, 2024

Targeting chronic inflammation to treat cognitive decline – interview with ADvantage Therapeutics

QUADSMaster

June 10, 2024

quadraScope Ventures one year update

QUADSMaster

May 14, 2024

quadraScope to present at the 2024 Longevity Leadership Conference

QUADSMaster

May 14, 2024

quadraScope to participate in the Longevity Investment panel at the 2024 Healthspan Summit

QUADSMaster

May 13, 2024

BIOIO

QUADSMaster

March 29, 2024

Platform for discovering and repurposing longevity drugs based on the precise understanding of their mechanisms of action

quadraScope will be speaking at Life Science Nation’s Redefining Early Stage Investments conference

QUADSMaster

March 16, 2024

Unlock Healthy Longevity: Supplements
Focus: Science | Biotech
February 29 – March 1, 2024
Singapore, Singapore + Virtual

QUADSMaster

February 24, 2024

Redefining Early Stage Investments
Focus: Biotech | Finance
March 25-27, 2024
Atlanta, GA + Virtual

QUADSMaster

February 24, 2024

Global Congress on Aging & Gerontology
Focus: Science | Public policy
April 8-9, 2024
Valencia, Spain + Virtual

QUADSMaster

February 24, 2024